Navigation Links
GenVec Reports Third Quarter 2009 Financial Results
Date:11/5/2009

ds. The decrease in both periods is primarily due to lower personnel costs, professional fees, reduced patient, site, lab, data management, monitoring and materials costs related to our TNFerade(TM) program, reduced materials costs related to our funded programs, and reduced general lab materials and supplies.

GenVec ended the third quarter of 2009 with $14.2 million in cash and investments.

"Based on existing contracts and collaborations, we anticipate revenues for 2009 will be between $14.0 million and $16.0 million. We project our cash burn to be between $12.0 million and $14.0 million for the 12 months ending September 30, 2010 although our spending will be heavily influenced by the availability of capital," commented Douglas J. Swirsky, GenVec's Senior Vice President and Chief Financial Officer. "Our primary focus remains on TNFerade and the PACT trial and we look forward to sharing additional data from this pivotal trial next year."

Third Quarter and Recent Highlights

  • GenVec has enrolled 277 patients in the pivotal PACT trial as of October 31, 2009.
  • GenVec's lead product candidate, TNFerade, was granted orphan drug designation by the FDA. Orphan drug designation provides potential financial and regulatory incentives including study design assistance, waiver of FDA user fees, tax credits, and up to seven years of market exclusivity upon marketing approval.
  • GenVec signed a contract with the SAIC for the development of influenza and HIV vaccines in support of the Vaccine Research Center (VRC) of the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH). This four-year contract has a total value of over $22 million if all options are exercised. Over the next year, GenVec will receive approximately $2.6 million under the base year of the contract.
  • GenVec was awarded an approximately $2.5 million Small Business Innovation and
    '/>"/>

SOURCE GenVec, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants
2. GenVec Expands Contract Supporting Malaria Vaccine Program
3. GenVec Reports Second Quarter 2009 Financial Results
4. GenVec Receives an Approximately $2.5 Million Grant to Support Novel Cell Line Development
5. GenVec Announces Registered Offering of $6 Million in Common Stock and Warrants
6. GenVec Announces Third Quarter 2009 Results Conference Call
7. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
8. QMed, Inc. Reports July Medicare SNP Enrollments
9. Phlo Affiliate Reports Expanded Coverage to Oregon Border
10. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
11. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... About Bioactive Material Bioactive ... are increasingly becoming popular due to their ability ... having a negative impact on the human health. ... tissue repair materials in surgical procedures. Bioactive materials ... glass-ceramics, and composites. The major end-users of bioactive ...
(Date:9/23/2014)... 23, 2014 Kamal Rashid , ... Education and Training Center (BETC) and research professor of ... BioTalk 2014 , an international two-day event focused on ... by Global Summits, the event will bring together leaders ... cells to develop and produce human therapeutics. “The growth ...
(Date:9/23/2014)... 2014 This is a professional ... the Phenolic Resin industry in Global and China.The ... including definitions, applications and industry chain structure. Global ... provided with a focus on history, developments, trends ... between the international and Chinese situation is also ...
(Date:9/23/2014)... Erlab , the expert in ... and Burdinola, supplier of laboratory furniture solutions, announce a ... hood. , By integrating Erlab’s GreenFumeHood ... now offer an innovative solution utilizing the patented technology ... best-in-class detection technology, and communication for security and monitoring ...
Breaking Biology Technology:Global Bioactive Material Market 2014-2018 2Worcester Polytechnic Institute's Biomanufacturing Expertise to be Featured in Berlin 2Worcester Polytechnic Institute's Biomanufacturing Expertise to be Featured in Berlin 3Phenolic Resin Industry (International, China) Development Policy and Plan Now Available at ReportsnReports.com 2Erlab Partners with Burdinola to Deliver an Innovative Filtered Fume Hood 2
... India, September 9 , ... Consulting Solutions for Health Care , ... the launch of its first business vertical-focused learning,solutions for ... initiative with the appointment of Candida Chandorkar as Vice,President ...
... WILMINGTON, N.C., Sept. 9 Jim Robison has been named ... several new Sanford Rose Associates executive search offices opening in ... Environmental Systems and CFO of House of Raeford Farms. With ... growing agribusiness, food processing, and distribution companies, Robison is a ...
... ... designed to find the genetic cause of Chiari-like Malformation and syringomyelia in dogs. Chiari-like malformation ... out of the skull and crowds the spinal cord, putting pressure on both the brain ... ...
Cached Biology Technology:Tata Interactive Systems Initiates Vertical-Focused Learning Solutions for Health Care, Pharmaceutical, and Biotechnology 2Tata Interactive Systems Initiates Vertical-Focused Learning Solutions for Health Care, Pharmaceutical, and Biotechnology 3Tata Interactive Systems Initiates Vertical-Focused Learning Solutions for Health Care, Pharmaceutical, and Biotechnology 4Sanford Rose Associates Opens Wilmington, N.C. Office 2DNA Genotek's Oragene●ANIMAL DNA Collection Kit Plays Key Role in Determining the Genetic Cause of Chiari Malformation in Dogs 2DNA Genotek's Oragene●ANIMAL DNA Collection Kit Plays Key Role in Determining the Genetic Cause of Chiari Malformation in Dogs 3
(Date:9/23/2014)... 23, 2014 Research and Markets  has ... Forecast and Opportunities, 2019" report to their offering. ... for enhancing security and protection in private as well ... The country,s government is focusing on using biometric systems ... other national IDs that are of crucial importance to ...
(Date:9/23/2014)... Florida , September 23, 2014 ... innovative companies in tech sector position for significant investor attention ... & services.  Companies in focus today are: NXT-ID, Inc. (NASDAQ: ... BABA ), Mobileye N.V. (NYSE: MBLY ), ... Ltd. (NASDAQ: RWLK) NXT-ID, Inc. (NASDAQ: ...
(Date:9/23/2014)... including humans, have parasitic DNA fragments called "jumping genes" ... in the process. And that phenomenon can result in ... University of Rochester now report that the "jumping genes" ... a multi-function protein stops keeping them in check in ... a study published today in Nature Communications , ...
Breaking Biology News(10 mins):India Biometrics Market Forecast and Opportunities, 2019 2India Biometrics Market Forecast and Opportunities, 2019 3Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 2Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 3Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 4Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 5Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 6Latest Blockbuster IPOs and Up Listings for Global Tech Stocks Attracting Major Attention as Traders Focus on Key Economic Data Due this Week 7A multi-function protein is key to stopping genomic parasites from 'jumping' 2
... study from the University of Rochester finds that there is ... it language capabilities above and beyond those of any other ... brain, each designed to accomplish different primitive tasks, in order ... of grammar used in forming a given sentence, the brain ...
... have developed a way to enhance how brain tumors appear ... for surgeons to identify and remove. Scientists at Ohio ... may one day be injected into the blood of patients ... In the journal Nanotechnology, researchers reported that ...
... An international research consortium including scientists from The ... (UTHealth) has identified a new genetic link to ... thorough understanding of the genetic nature of the ... Systemic scleroderma is a profoundly disabling autoimmune disease ...
Cached Biology News:Sign language study shows multiple brain regions wired for language 2Sign language study shows multiple brain regions wired for language 3Tiny particles may help surgeons by marking brain tumors 2Study reveals new genetic link to scleroderma 2Study reveals new genetic link to scleroderma 3
... BR4i refrigerated multifunction centrifuges are equally capable of ... low sound level with a large range of ... rotor exchange system without tools ensures that the ... Instant rotor exchange (5 sec.) ...
... ,Each upright model provides fast pull-down, rapid ... for refrigerated blood. The BBR25 and BBR55 ... complete blood storage monitoring. Models BBR6, BBR11, ... HemaPro 101 alarm/monitor. All of these models ...
Sterile, individually wrapped, 4mm Cuvettes...
... form of Tobacco Etch Virus (TEV) protease ... significantly more stable than native TEV protease, ... recognizes a seven amino acid (Glu-Asn-Leu-Tyr-Phe-Gln-Gly, cleaving ... for removing affinity tags from fusion proteins ...
Biology Products: